Transverse myelitis

86,504 views 49 slides Mar 30, 2017
Slide 1
Slide 1 of 49
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49

About This Presentation

Transverse myelitis ;Definition
Etiology
Presentation
Diagnosis
Treatment
Prognosis


Slide Content

Transverse Myelitis Dr /Reyad Alfaky

Transverse Myelitis Definition Etiology Presentation Diagnosis Treatment Prognosis

Definition Transverse myelitis (TM) is a segmental spinal cord injury caused by acute inflammation

DEFINITION Transverse myelitis (TM) as evidence of spinal cord inflammation by an MRI-documented enhancing lesion, or CSF pleocytosis (>10 cells), or increased immunoglobulin G index. may be Postinfectious postvaccination , or associated with multiple sclerosis.

DEFINITION acute transverse myelopathy is a broader term refers to any process that acutely impairs spinal cord function.

Types ; Transverse myelitis (TM) Complete Transverse Myelitis Partial or incomplete Transverse Myelitis

Progression ; Transverse myelitis (TM) The progression is rapid time to maximal disability is more than 4 hr and fewer than 21 days. Acute (over minutes or hours), subacute (over days or weeks)

Small children Small children, 3 yr of age and younger onset develop spinal cord dysfunction over hours to a few days clinical loss of function is often severe and may seem complete recovery slow recovery (weeks to months) is common in these cases it is likely to be incomplete. independent ambulation in these small children is approximately 40%.

older children onset is also rapid with a nadir in neurologic function occurring between 2 days and 2 wk recovery is more rapid more likely to be complete.

pathophysiology TM is often preceded within the previous 1-3 wk by mild nonspecific illness minimal trauma immunization. Postinfectious etiology largely predominates in children.

pathophysiology Three hypotheses have been proposed: Cell mediated autoimmune response autoimmune vasculitis direct viral invasion of spinal cord.

Transverse Myelitis (TM) Immune-mediated process results in neural injury to the spinal cord Varying degrees of weakness, sensory alterations and autonomic dysfunction Up to half of idiopathic cases will have a preceding respiratory or gastrointestinal illness

Etiology Post or parainfectious Respiratory or gastrointestinal infections within 3 to 8 weeks Direct invasion of spinal cord Systemic autoimmune diseases Systemic Lupus Erythematosus (SLE) Multiple Sclerosis

EPIDEMIOLOGY Incidence: 1 to 4/million per year affecting all ages with bimodal peaks between the ages of 10 and 19 years and 30 and 39 years. Boys and girls are affected equally

Clinical presentation Combination of ; Sensory Motor bladder symptoms

clinical course The course of ATM in children proceeds through three stages: initial motor loss precedes sphincter dysfunction in most patients, there is often a sensory loss below certain levels, usually over 2 to 3 days plateau phase: the mean duration of plateau is 1 week recovery phase.

Clinical presentation Features of spinal cord lesion Band like sensation (pressure, pain, numbness) over the trunk Bladder symptoms (incontinence, difficulty urinating, retention) Horizontal level of sensory loss Unilateral posterior column loss pyramidal weakness contralateral spinothalamic loss

Clinical presentation Typical presentation Prior history of fever (nonspecific viral illness) ATM, the onset of spinal cord dysfunction usually progress in 4 hours to 21 days, the patient's signs usually plateau and evolve toward spasticity/hyperreflexia. Back pain, paresthesias , radicular pain in the legs Bilateral, asymmetric, unilateral, acute-sub acute progressive leg weakness with any of the features of spinal cord lesion

Clinical presentation Urinary retention is an early finding; incontinence occurs later in the course.

HISTORY Other findings may include priapism vision loss ( neuromyelitis optica ), as well as spinal shock subsequent autonomic dysreflexia

Physical Examination Extreme irritability extent of weakness is assessed by how vigorously the child resists examination Fever, hypertension, tachycardia, meningeal signs may be present, in which cases CNS infection need to be ruled out; point tenderness over the spine may point to trauma or infection Neurologic examination directed to visual acuity and color vision funduscopic examination for optic nerve head pallor (optic neuritis)

causes the pain and irritability commonly seen in children with TM Pain in TM may be as a result of neuropathic pain from nerve root inflammation nociceptive pain from dural inflammation muscle spasm from motor dysfunction bladder distension from dysautonomia psychological distress from loss of motor control dysesthesia from demyelination of spinothalamic tract.

Physical Examination Increased tone, spastic weakness is usually symmetric, legs more than arms Reflexes are usually brisk, with positive Babinski sign. Sensory ataxia, a sensory level (a partial level is commonly seen) that may spare joint position and vibration, may be present.

Physical Examination Sphincter dysfunction can lead to emergent complication of urinary retention or incontinence; check for loss of anal wink bladder dilatation, and large volume of post void residual (>100 mL).

Laboratory Aids MRI with and without contrast enhancement is essential to rule out a mass lesion requiring neurosurgical intervention MRI of the brain is also indicated lumbar puncture is indicated. neuromyelitis optica (NMO; Devic syndrome) the serum of all patients should be analyzed for the NMO antibody. TM, older children with the condition should have serum studies sent for autoimmune disorders, especially systemic lupus erythematosus.

Laboratory Aids MRI and CSF analysis are the two most important tests and are mandatory in suspect ATM. Enhancing spinal cord lesion or pleocytosis or increased IgG index is required for the diagnosis. If both tests are negative, repeat tests in 2 to 7 days is recommended.

Laboratory Aids The first priority in acute myelopathy is to rule out structural cause compressive myelopathy. spinal MRI The second priority is to define the presence/absence of spinal cord inflammation and to rule out other CNS infection. LP Third priority is to define extent of demyelination. Gadolinium-enhanced MRI of the brain evoked potential studies (e.g., visual evoked potential, somatosensory evoked potential)

Laboratory Aids Lumbar puncture is usually done after imaging, often shows normal or slightly increased protein mild pleocytosis with lymphocyte predominance. Elevation of IgG index and presence of oligo clonal bands are indicative of MS or other systemic inflammatory disease. CSF gram stain, bacterial, viral, and fungal culture, VDRL, lyme antibodies, and PCR of specific viruses should all be negative in ATM.

Laboratory Aids Other ESR and ANA RPR, Lyme titer underlying metabolic disorder including VLCFA. Viruses associated with ATM include the herpes viruses (EBV, VZV, HSV), CMV mumps, rubella, influenza, hepatitis A, B, C, HIV. Positive IgM or greater than fourfold increase in IgG levels on two successive tests to a specific infectious agent suggests diagnosis of parainfectious ATM.

Differentiate From GB Syndrome Progressive lower limb weakness (proximal>distal) Ascends to upper limbs & bifacial weakness Arreflexia Normal sensory examination No bladder symptoms No band like sensation No level for sensory loss

Characteristics Transverse Myelitis Guillain-Barre Syndrome Motor findings Paraparesis or quadriparesis Ascending weakness LE > UE in the early stages Sensory findings Usually can diagnose a spinal cord level Ascending sensory loss LE > UE in the early stages Autonomic findings Early loss of bowel and bladder control Autonomic dysfunction of the (CV) system Cranial nerve None EOM palsies or facial weakness Electrophysiologic findings EMG/NCV findings may be normal or may implicate the spinal cord: prolonged central conduction on somatosensory evoked potential (SEP) latencies or missing SEP in conjunction with normal sensory nerve action potentials EMG/NCV findings confined to the PNS: motor and/or sensory nerve conduction velocity reduced, distal latencies prolonged; conduction block; reduced H reflex usually present MRI findings Usually a focal area of increased T2 signal with or without gadohnium enhancement Normal CSF Usually, CSF pleocytosis and/or increased IgG index Usually, elevated protein in the absence of CSF pleocytosis

Acute Transverse Myelopathy The three main categories in the differential diagnosis of ATM are demyelination, including multiple sclerosis (MS) neuromyelitis optica (NMO), and idiopathic transverse myelitis;

DIAGNOSTIC CRITERIA FOR TRANSVERSE MYELITIS Bilateral (not necessarily symmetric) sensorimotor and autonomic spinal cord dysfunction Clearly defined sensory level Progression to nadir of clinical deficits between 4 hours and 21 days after symptom onset Demonstration of spinal cord inflammation: cerebrospinal fluid pleocytosis or elevated IgG index,or MRI revealing a gadolinium-enhancing cord lesion Exclusion of compressive, postradiation , neoplastic , and vascular causes

CRITERIA FOR DIAGNOSIS OF ACUTE TRANSVERSE MYELITIS Inflammation within the spinal cord demonstrated by CSF pleocytosis or elevated IgG index or gadolinium enhancement (If none of the inflammatory criteria is met at symptom onset, repeat MRI and LP evaluation between 2–7 days following symptom onset). IgG index = : (CSF IgG + serum IgG) (CSF albumin + serum albumin)

MANAGEMENT OF TM Care of the paraplegic patient Multidisciplinary rehab approach is key Intravenous Steroids Plasma Exchange (PLEX)

Chronic Management of TM

Intravenous Steroids Corticosteroids have multiple mechanisms of action including antiinflammatory activity immunosuppressive properties antiproliferative actions. methylprednisolone therapy high-dose methylprednisolone (30mg /kg (max 1 g) IV daily for 3–7 days) is typically first-line treatment early in the course is effective in shortening the duration of the disease and in improving the outcome.

Intravenous Steroids methylprednisolone therapy If there is a poor response to high-dose steroids, other therapeutic approaches include ; intravenous immunoglobulin plasma exchanges Rituximab cyclophosphamide.

Plasma Exchange (PLEX) PLEX is often initiated if a patient has moderate to severe TM inability to walk markedly impaired autonomic function sensory loss in the lower extremities and exhibits little clinical improvement after instituting 5 to 7days of intravenous steroids.

Natural History and Prognosis The progression of symptoms in ATM often slows within 2 to 3 weeks of onset with a corresponding improvement in CSF and MRI abnormalities recovery :- Evidence of at least some recovery is expected to begin within 6 months most patients show some improvement in neurologic function within 8 weeks although recovery can take a more prolonged course of up to 2 years

Follow-Up Residual neurologic deficits include fixed weakness sensory, or autonomic deficits. Sphincter dysfunction improves more slowly than the other deficits.

Follow-Up ATM may be the presenting feature of MS, especially in patients with partial ATM abnormal initial brain MRI, in such cases, follow up MRIs should be considered.

Follow-Up History of other neurologic symptoms such as internuclear ophthalmoplegia optic neuritis focal weakness and numbness that lasted at least 24 hours to days, have now resolved completely other lesions on brain/spine MRI at the time of presentation, and subsequent new MRI lesions

Prognosis pediatric outcomes are better than in adults, with children often regaining complete function. Spontaneous complete recovery (within weeks or months) in -40-50% of cases. Residual deficits (weakness of LL, bladder dysfunction) occur in the remaining cases. The majority of patients with ATM have monophasic disease without recurrence.

Outcomes 1/3 pts have a complete recovery 1/3 pts have some residual deficit 1/3 pts have no improvement from nadir

Prognosis  risk factors for unfavorable outcomes at presentation, including rapid progression to maximal neurologic deficit (<24 hours) severe motor weakness spinal shock back pain as the initial complaint, and sensory disturbances at the cervical level

Prognosis better course Older age increased deep tendon reflexes presence of the Babinski sig

Thank you
Tags